Evidence map›Paper›PMID 42030193›Full record

ArticleAging cell2026

Decellularized Aged Bruch's Membrane Confers Unique Biochemical Cues to Retinal Pigment Epithelium for In Vitro Modeling of Age-Related Macular Degeneration.

Blanca Molins, Mercedes Soledad Nabaes Jodar, Eliandre de Oliveira, Josep Maria Estanyol, Esther Peña, Jaione Bezunartea, María Hernández, Marc Figueras-Roca, Alfredo Adan

Abstract read
In one paragraph

Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Blanca MolinsGroup of Ocular Inflammation: Clinical and Experimental Studies, Institut D'investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID https://orcid.org/0000-0003-0941-9134
Mercedes Soledad Nabaes JodarGroup of Ocular Inflammation: Clinical and Experimental Studies, Institut D'investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Eliandre de OliveiraProteomics Laboratory, Biomolecular Analysis Unit. Scientifical and Technological Centers, University of Barcelona, Barcelona, Spain.
Josep Maria EstanyolProteomics Laboratory, Biomolecular Analysis Unit. Scientifical and Technological Centers, University of Barcelona, Barcelona, Spain.
Esther PeñaResearch Institute Sant Pau (IR SANT PAU), CIBERCV, Barcelona, Barcelona, Spain.
Jaione BezunarteaRetinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.
María HernándezRetinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.
Marc Figueras-RocaGroup of Ocular Inflammation: Clinical and Experimental Studies, Institut D'investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Alfredo AdanGroup of Ocular Inflammation: Clinical and Experimental Studies, Institut D'investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Funding

Instituto de Salud Carlos III PI22/00782Novartis Farmacéutica
6 · The paper itself

Abstract

Age-related macular degeneration (AMD), a chronic inflammatory disease, is a major cause of irreversible blindness worldwide. It involves the degeneration of the retinal pigment epithelium (RPE) and the accumulation of deposits between the RPE and the Bruch's membrane (BrM), ultimately leading to photoreceptor death. The multifactorial and chronic nature of AMD makes it challenging to model in vitro. We developed a biomaterial based on decellularized BrM (dECM-BrM) from aged donors to evaluate its ability to induce an AMD-like phenotype in RPE monolayers. BrM from 5 young and 5 aged human donors was decellularized and the protein profile analyzed by LC-MS/MS. dECM-BrM was then used as a coating substrate for RPE culture. A total of 281 proteins were identified and proteomic analysis screened 49 differentially expressed proteins in aged dECM-BrM. Gene Ontology analysis showed that they were associated with extracellular region, antioxidant activity, lipid metabolism and transport. Moreover, the KEGG pathway related to complement and coagulation cascade was significantly enriched. RPE culture on aged dECM-BrM allowed RPE polarization and after 60 days, transepithelial electrical resistance significantly decreased compared to RPE grown on young dECM-BrM, accompanied by increased IL-33 secretion and marked expression of drusen components such as vitronectin and apolipoprotein E, lipid deposition and complement factors C3 and C9. We showed a successful approach to obtain a BrM mimic based on decellularized BrM that ensured cellular removal while preserving ECM structure and identified differentially expressed proteins in aged dECM-BrM that may provide specific biochemical cues fundamental to model AMD in vitro.

Indexed as

Bruch MembraneMacular DegenerationModels, BiologicalRetinal Pigment EpitheliumAgedHumansProteomicsage‐related macular degenerationBruch's membranedecellularized tissuedisease modelingextracellular matrixouter blood retinal barrierproteomicsretinal pigment epithelium

Identifiers

PMID42030193
PMCPMC13108670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.